Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACE2,Angiotensin-converting enzyme 2,40347,156,2.24 [1.86-2.70],1.8357024047558442e-17
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACY1,Aminoacylase-1,41078,162,1.71 [1.40-2.08],9.478398845329142e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,40837,159,2.77 [2.12-3.62],6.991116925985415e-14
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAMTSL2,ADAMTS-like protein 2,35730,144,4.24 [3.04-5.92],2.2541723823421977e-17
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,35570,141,2.19 [1.71-2.79],3.637919478537764e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,41246,167,3.51 [2.29-5.39],8.283427119160919e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,41381,163,3.06 [2.38-3.92],1.936172972939949e-18
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRG1,Adhesion G-protein coupled receptor G1,40885,161,1.77 [1.56-2.00],6.323255257621684e-20
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AGXT,Serine--pyruvate aminotransferase,41078,162,1.60 [1.37-1.86],3.901614371210991e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,41580,165,13.39 [7.53-23.81],1.0172448655367297e-18
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOF,Apolipoprotein F,35749,144,0.45 [0.36-0.57],1.315283572544654e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AREG,Amphiregulin,40885,161,2.25 [1.76-2.87],9.803239860931863e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,40144,155,1.71 [1.44-2.03],5.764020542688852e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCAM,Basal cell adhesion molecule,41086,162,4.95 [3.37-7.29],4.533552985822149e-16
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,41438,159,2.23 [1.93-2.58],4.840256710089172e-27
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,41229,162,2.04 [1.59-2.60],1.3124101641505572e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,34922,142,5.36 [3.56-8.08],1.040478704199377e-15
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA9,Carbonic anhydrase 9,41451,161,2.08 [1.63-2.64],2.227649222620412e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,41229,162,2.41 [1.82-3.19],7.476547556128965e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,40144,155,1.95 [1.54-2.47],3.560461970484987e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,41186,167,3.70 [2.43-5.65],1.330509079948173e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,41438,159,2.95 [2.08-4.20],1.4443823227994242e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,35725,144,4.18 [2.98-5.86],1.3269372658132583e-16
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,40774,156,1.85 [1.48-2.32],6.761162157683793e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH2,Cadherin-2,41078,162,2.74 [1.91-3.93],4.170053099225718e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH6,Cadherin-6,41078,162,2.81 [2.13-3.72],4.2799493229036854e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDHR2,Cadherin-related family member 2,40885,161,1.87 [1.53-2.30],1.2119725178558411e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,41128,165,8.14 [4.81-13.80],6.5647722335724986e-15
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CFHR5,Complement factor H-related protein 5,35283,142,0.51 [0.40-0.65],4.111448291929966e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHI3L1,Chitinase-3-like protein 1,40174,157,1.57 [1.36-1.81],9.019901881563055e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,41346,161,2.79 [2.03-3.82],1.7277393685189582e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLSTN2,Calsyntenin-2,41546,162,2.56 [2.02-3.26],1.7765185448113282e-14
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNDP1,Beta-Ala-His dipeptidase,41229,162,0.51 [0.40-0.65],6.774256170463654e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNTNAP2,Contactin-associated protein-like 2,41034,163,2.20 [1.66-2.91],3.4719199667022473e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,41078,162,3.28 [2.50-4.30],7.365336678047723e-18
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,34959,138,3.01 [2.42-3.73],1.2543295389770248e-23
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",34777,137,1.91 [1.56-2.35],6.445308766901479e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,35611,143,3.08 [2.05-4.63],6.84679185849363e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,41246,167,8.54 [5.09-14.35],5.204178517709242e-16
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,41246,167,3.47 [2.22-5.43],5.030302520679543e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,35749,144,2.55 [1.91-3.41],2.867462329044241e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSD,Cathepsin D,38371,152,2.31 [1.89-2.84],9.033823171573656e-16
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXADR,Coxsackievirus and adenovirus receptor,41034,163,2.01 [1.63-2.49],1.1718765210213163e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL8,Interleukin-8,40795,160,1.54 [1.37-1.74],5.632535588858907e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,41438,159,5.47 [3.51-8.53],6.105716354467683e-14
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DPP10,Inactive dipeptidyl peptidase 10,41034,163,3.13 [2.49-3.95],3.143026321226611e-22
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,40611,161,2.46 [1.79-3.37],2.6743687521820547e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,41451,161,2.57 [1.89-3.50],2.137017347131621e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,41160,162,3.01 [2.02-4.49],5.8059817827337184e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,41580,165,8.48 [4.82-14.91],1.1122762981376937e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,41580,165,5.95 [4.06-8.71],4.526248309514181e-20
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39797,157,1.65 [1.40-1.95],2.8050023879739723e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,40144,155,2.10 [1.73-2.55],8.450758020118985e-14
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,39628,157,2.67 [2.05-3.49],4.486381051372274e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,41389,161,2.91 [2.01-4.22],1.7213595606398846e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,35725,144,1.74 [1.42-2.13],8.58796710894745e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCN2,Ficolin-2,40890,160,0.47 [0.38-0.59],7.758475523746103e-12
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,41193,165,7.29 [4.62-11.49],1.2238527846403109e-17
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,40983,166,3.79 [2.71-5.30],7.245135460685682e-15
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,41438,159,2.17 [1.64-2.86],5.30037602505529e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,41312,163,4.33 [2.55-7.34],5.6295356462760215e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,41580,165,2.39 [2.03-2.81],1.4839506965747216e-25
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GGT1,Glutathione hydrolase 1 proenzyme,41021,162,2.39 [1.97-2.90],6.04759596065162e-19
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",35730,144,1.93 [1.52-2.45],8.256888219721379e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPRC5C,G-protein coupled receptor family C group 5 member C,35559,140,1.79 [1.54-2.08],4.51631658501716e-14
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,40889,161,3.87 [2.36-6.35],8.891252608395151e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",40885,161,1.82 [1.53-2.16],1.6950155693030664e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HAO1,Hydroxyacid oxidase 1,41451,161,1.33 [1.20-1.47],2.9582967342496783e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,41392,161,2.01 [1.68-2.41],1.6900859487824868e-14
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,41086,162,2.95 [2.13-4.08],7.080631503661554e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HGF,Hepatocyte growth factor,41546,162,3.78 [2.87-4.96],1.4547499845787448e-21
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,35585,142,1.66 [1.39-1.98],2.0294405853103053e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,40903,159,3.85 [2.70-5.50],1.2155680861695194e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,41229,162,0.39 [0.30-0.51],6.6804617068107416e-12
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGFBP7,Insulin-like growth factor-binding protein 7,41580,165,3.34 [2.81-3.97],2.1487455376812282e-42
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGFBPL1,Insulin-like growth factor-binding protein-like 1,41078,162,3.27 [2.39-4.46],9.524033945421649e-14
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,40885,161,3.30 [2.65-4.11],1.7866817879073366e-26
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,41246,167,2.61 [1.95-3.48],6.973981220404248e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,41229,162,3.49 [2.50-4.89],2.7989813174423535e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,41546,162,2.98 [2.03-4.38],2.911868156248809e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,41021,162,4.29 [2.76-6.68],1.0705255543362951e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,41034,163,2.10 [1.68-2.63],5.3064932630446715e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,41034,163,2.82 [2.13-3.73],4.717860376917227e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL6ST,Interleukin-6 receptor subunit beta,41078,162,4.66 [2.84-7.65],1.1376261989356278e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGA5,Integrin alpha-5,41086,162,5.94 [3.76-9.41],2.7475737126854145e-14
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,40838,159,3.09 [2.14-4.48],2.2764892503031923e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,35730,144,4.09 [3.22-5.18],3.8054903103152e-31
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KRT18,"Keratin, type I cytoskeletal 18",40885,161,1.56 [1.37-1.78],6.630378971079566e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KRT8,"Keratin, type II cytoskeletal 8",34626,133,1.44 [1.29-1.61],1.29969883885403e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,40885,161,2.00 [1.57-2.56],2.598076361327512e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,35778,144,2.49 [1.90-3.26],4.187753905458352e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,41059,166,2.92 [1.98-4.29],5.7549426864483584e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LIFR,Leukemia inhibitory factor receptor,41034,163,3.59 [2.29-5.63],2.7114125603595494e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,41580,165,4.84 [3.45-6.77],4.296088308207163e-20
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,40852,166,3.07 [2.07-4.56],2.565668240427656e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MME,Neprilysin,40885,161,1.72 [1.48-2.00],1.839060697204754e-12
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MMP7,Matrilysin,40282,156,2.48 [1.85-3.32],1.2941385139796096e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,41438,159,2.43 [1.83-3.22],8.583879552618361e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MUC13,Mucin-13,40116,153,2.24 [1.80-2.78],2.983451739282145e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,35570,141,3.55 [2.49-5.06],2.4491973477181724e-12
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,41546,162,6.87 [4.60-10.27],6.005456929047151e-21
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NOTCH3,Neurogenic locus notch homolog protein 3,41580,165,3.25 [2.24-4.73],6.20621403779348e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NRP1,Neuropilin-1,41305,162,3.32 [2.18-5.05],2.092231433768775e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NT5E,5'-nucleotidase,41193,165,1.96 [1.62-2.38],4.549589952364442e-12
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,35669,140,2.20 [1.69-2.87],5.456462920657157e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,35655,142,2.31 [1.71-3.10],3.5094362406824365e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,41078,162,3.28 [2.40-4.49],1.2002142054919438e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDGFRA,Platelet-derived growth factor receptor alpha,41078,162,3.79 [2.58-5.58],1.1492515625920198e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,34698,142,2.01 [1.56-2.57],4.567455814213077e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,41546,162,2.66 [1.94-3.65],1.051605186626613e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,40567,156,3.44 [2.51-4.73],1.93994925686614e-14
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,41193,165,4.76 [3.12-7.25],3.9547970065500666e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLAU,Urokinase-type plasminogen activator,41086,162,2.08 [1.67-2.59],3.791375763468199e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,40791,166,3.33 [2.16-5.12],4.957998685454753e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,41394,163,5.30 [3.36-8.37],7.541763889111144e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,41330,164,2.61 [1.96-3.47],3.8147721203187646e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRTG,Protogenin,41451,161,3.32 [2.29-4.80],2.1194818666660022e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,39933,153,1.85 [1.52-2.24],4.80680563489737e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,41119,167,4.83 [3.40-6.85],1.2140629116199813e-18
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,41438,159,3.66 [2.41-5.54],9.375358989080215e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,41078,162,2.41 [1.87-3.10],7.759407198301483e-12
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,41451,164,4.10 [3.16-5.32],3.716092950517568e-26
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEZ6L2,Seizure 6-like protein 2,40885,161,3.78 [2.63-5.43],7.661713491175325e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,41246,167,2.23 [1.68-2.97],3.7277701255203495e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,41034,163,3.05 [2.15-4.31],3.152680084890102e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC7,Sialic acid-binding Ig-like lectin 7,41078,162,3.25 [2.13-4.95],4.550599984999727e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,40955,161,5.48 [4.13-7.27],3.592997926108708e-32
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,41119,167,3.15 [2.30-4.32],1.1771342230050196e-12
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPON2,Spondin-2,40895,160,3.56 [2.50-5.07],1.8163283902577944e-12
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,41510,164,2.36 [1.80-3.11],7.08610664766543e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SRPX,Sushi repeat-containing protein SRPX,35725,144,3.85 [2.73-5.43],1.3184176372145916e-14
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SULT2A1,Bile salt sulfotransferase,41034,163,1.66 [1.41-1.96],7.830979969224335e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TACSTD2,Tumor-associated calcium signal transducer 2,36444,140,2.93 [2.21-3.90],1.2249358202649304e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TGFBI,Transforming growth factor-beta-induced protein ig-h3,40834,159,3.91 [2.51-6.11],1.924633901436973e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",THBS2,Thrombospondin-2,41086,162,3.67 [2.98-4.52],2.9484448470157523e-34
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIMP1,Metalloproteinase inhibitor 1,40637,161,4.07 [3.16-5.24],1.187957141795933e-27
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,41546,162,2.28 [1.69-3.07],7.39136727843985e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,41047,167,4.43 [3.08-6.36],8.883117163932782e-16
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,41438,159,3.65 [2.35-5.68],8.909566379833544e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,41510,165,2.64 [1.92-3.63],2.224333487583438e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,35730,144,2.68 [1.93-3.73],4.827626810943369e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VAMP5,Vesicle-associated membrane protein 5,40347,156,1.61 [1.38-1.87],1.542354214801676e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,41168,160,5.46 [3.84-7.76],3.150431924569957e-21
